Overview
Continuous Oxytocin Infusion Versus Pulsatile Intravenous Oxytocin for Augmentation of First Stage of Labor
Status:
Unknown status
Unknown status
Trial end date:
2017-02-01
2017-02-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
Comparing continuous intravenous oxytocin infusion with pulsatile administration of intravenous oxytocin for augmentation of the first stage of labor.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Ain Shams Maternity HospitalTreatments:
Oxytocin
Criteria
Inclusion Criteria1. Women in labor (cervical dilatation 3-4 centimeters) who require augmentation of first
stage of labor.
2. Single viable fetus.
3. Rupture of membranes before augmentation of labor.
4. Cephalic presentation.
5. Term pregnancy.
Exclusion Criteria:
1. Malpresentation.
2. Induction of labor by prostaglandins.
3. Any uterine previous surgery.
4. Fetal anomalies.
5. Premature labor.
6. Previous cesarean section.
7. Any uterine anomalies.
8. Multiple pregnancy.